For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Viiv Healthcare Company

USPTO Granted Patents = 40

EPO Patents = 26

Trademarks = 26

Forward Citations = 137

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Brian Alvin Johns (21 out of 55 patents)

Takashi Kawasuji (10 out of 16 patents)

Yoshiyuki Taoda (10 out of 31 patents)

4. Steven N Goodman (9 out of 9 patents)

5. Huan Wang (9 out of 10 patents)

6. Jason Gordon Weatherhead (9 out of 16 patents)

7. Toshikazu Hakogi (9 out of 10 patents)

8. Matthew David Kowalski (9 out of 9 patents)

9. Douglas Matthew Mans (9 out of 10 patents)

10. Yasunori Aoyama (8 out of 11 patents)

11. Teruhiko Taishi (6 out of 10 patents)

12. Daiki Nagamatsu (4 out of 5 patents)

13. Hiroshi Yoshida (4 out of 56 patents)

14. David Margolis (3 out of 6 patents)

15. William R Spreen (3 out of 3 patents)

Core Competencies:

HIV Therapy

Antiviral Therapy

Pharmaceutical Compositions

HIV Integrase Inhibitors

Carbamoylpyridone Derivatives

Substituted Pyridinones

Therapeutic Delivery

Synthesis Processes

Prodrugs

Regimens for HIV Treatment

Compositions for HIV Treatment

Chemical Compounds

40 patents: Sort by Forward Citations

1. 12178815 - Regimens for treating HIV infections and aids (2024-12-31),

2. 12138264 - Pharmaceutical compositions (2024-11-12),

3. 12011506 - Combination and uses and treatments thereof (2024-06-18),

4. 11564921 - Regimens for treating HIV infections and AIDS (2023-01-31),

5. 11492361 - Compounds useful in HIV therapy (2022-11-08),

6. 11267823 - Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1',2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity (2022-03-08),

7. 11234985 - Antiviral therapy (2022-02-01),

8. 11224597 - Pharmaceutical compositions (2022-01-18),

9. 11117904 - Compositions and methods for the delivery of therapeutics (2021-09-14),

10. 10927129 - N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity (2021-02-23),

11. 10758531 - Regimens and compositions for treating HIV infections and AIDS (2020-09-01),

12. 10654871 - Process for preparing (3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide (2020-05-19),

13. 10654870 - Process for preparing substituted pyridinones as intermediates in the preparation of polycyclic carbamoylpyridone derivatives (2020-05-19),

14. 10647728 - Process for preparing (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-Hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid (2020-05-12),

15. 10426780 - Antiviral therapy (2019-10-01),

ViiV Healthcare is a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV. With a focus on innovation and collaboration, ViiV Healthcare strives to transform the lives of people affected by HIV by providing innovative antiretroviral therapies, dedicated support programs, and extensive research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

40 Patents

#11 in Research Triangle Park, NC

#191 in North Carolina

#8,350 in US

#16,572 in the World

Research Triangle Park, NC, United States of America

Viiv Healthcare Company

Forward Citations = 137

44 inventors:

Brian Alvin Johns (21 out of 55 patents)

Takashi Kawasuji (10 out of 16 patents)

Yoshiyuki Taoda (10 out of 31 patents)

4. Steven N Goodman (9 out of 9 patents)

5. Huan Wang (9 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…